Hisakazu Yamagishi
Overview
Explore the profile of Hisakazu Yamagishi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
177
Citations
2171
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shigematsu K, Komori N, Ideno M, Yamagishi H
Neurosci Lett
. 2024 Mar;
825:137705.
PMID: 38428725
Introduction: The antibody drugs targeting β-amyloid in Alzheimer's disease pose risks of inflammation and vascular damage. It is known that neprilysin, an endogenous enzyme responsible for β-amyloid degradation, is reduced...
2.
Mayanagi S, Oba K, Aoyama T, Tanaka K, Kanda M, Honda M, et al.
Anticancer Res
. 2023 Jun;
43(7):3089-3095.
PMID: 37352002
Background/aim: The incidence of chemotherapy-related adverse events in colorectal cancer patients with renal insufficiency has been compared to patients with normal renal function in only a few studies. The purpose...
3.
Yoshino T, Oki E, Misumi T, Kotaka M, Manaka D, Eto T, et al.
J Clin Oncol
. 2022 May;
40(29):3419-3429.
PMID: 35512259
Purpose: The phase III ACHIEVE trial conducted in Japan was one of six prospective studies included in the International Duration Evaluation of Adjuvant Therapy collaboration, which explored whether 3 months...
4.
Yamagishi H, Shigematsu K
JMA J
. 2022 Feb;
5(1):36-43.
PMID: 35224258
Regenerative medicine is a medical treatment that aims to restore lost human body functions by regenerating missing or dysfunctional organs and tissues using stem cells, etc. There are three major...
5.
Shigematsu K, Komori N, Tahara K, Yamagishi H
Acta Neurol Scand
. 2021 Oct;
145(1):119-122.
PMID: 34716582
Background: Mesenchymal stem cells are expected to have a therapeutic effect on progressive neurodegenerative diseases for which there is currently no fundamental treatment. Aims Of The Study: The aim is...
6.
Shigematsu K, Yamagishi H
Med Hypotheses
. 2021 Jun;
153:110623.
PMID: 34144407
No abstract available.
7.
Shigematsu K, Yamagishi H
Clin Neurol Neurosurg
. 2021 Apr;
205:106641.
PMID: 33901748
No abstract available.
8.
Shigematsu K, Takeda T, Komori N, Tahara K, Yamagishi H
Med Hypotheses
. 2021 Apr;
150:110572.
PMID: 33799163
We propose the intravenous administration of autologous adipose-derived stem cells as a new treatment for Alzheimer's disease. We hypothesize that the stem cells will secrete neprilysin in the brain to...
9.
Matsuo Y, Morita H, Yamagishi H, Nakamura M, Takeshima Y, Nakagawa I, et al.
Hum Cell
. 2021 Mar;
34(3):819-824.
PMID: 33677815
Mesenchymal stem cells (MSCs) have recently made significant progression in multiple clinical trials targeting several clinical disorders and in the modulation of immune responses. In the present study, we isolated...
10.
Hagiwara A, Otsuji E, Yamagishi H
Nihon Geka Gakkai Zasshi
. 2012 Oct;
113(5):446-50.
PMID: 23061367
In surgery for the treatment of locally advanced rectal cancers affecting the intrapelvic nerves, when an affected nerve is resected in extended surgery to achieve radical cure, the resection results...